Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Profound Medical Corp
PROFCurrent price
4.78 USD
+0.06 USD (+1.27%)
Last closed
6.69 CAD
Company
www.profoundmedical.com
ISIN
CA74319B5027
Sector
Healthcare
Industry
Medical Devices
Exchange
TO
Capitalization
200 064 880 CAD
Yield for 12 month
-37.46 %
1Y
3Y
5Y
10Y
15Y
PROF
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada. Address: 2400 Skymark Avenue, Mississauga, ON, Canada, L4W 5K5
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
34.64 CADP/E ratio
–Dividend Yield
–Current Year
+14 782 572 CAD
Last Year
+9 964 395 CAD
Current Quarter
+5 128 224 CAD
Last Quarter
+3 919 873 CAD
Current Year
+9 740 165 CAD
Last Year
+6 065 284 CAD
Current Quarter
+3 493 559 CAD
Last Quarter
+2 499 750 CAD
Key Figures PROF
1 year
3 years
5 years
10 years
EBITDA
-32 126 000 CAD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-36.19 %
PEG Ratio
–
Return On Equity TTM
-60.70 %
Wall Street Target Price
34.64 CAD
Revenue TTM
10 680 000 CAD
Book Value
2.01 CAD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
84.40 %
Dividend Yield
–
Gross Profit TTM
7 037 000 CAD
Earnings per share
-1.56 CAD
Diluted Eps TTM
-1.56 CAD
Most Recent Quarter
IV 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-260.45 %
Dividend Analytics PROF
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History PROF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– CAD
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
16.10.2019
Stock Valuation PROF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
8.81
Price Sales TTM
18.73
Enterprise Value EBITDA
-7.93
Price Book MRQ
2.38
Financials PROF
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PROF
For 52 weeks
5.58 CAD
15.75 CAD
50 Day MA
8.95 CAD
Shares Short Prior Month
71 528
200 Day MA
10.72 CAD
Short Ratio
9.81
Shares Short
77 631
Short Percent
0.31 %
BeatStart